Retrospektive Analyse der Inzidenz und der Kosten medikamentöser Antitumortherapie (Chemotherapie, „Small Molecules“, zielgerichtete Antikörpertherapie, Immuncheckpoint-Inhibitoren) in der letzten Lebensphase bei PatientInnen mit soliden Tumoren in Krems

Kreye, Gudrun (PI)

Division of Internal Medicine 2 (University Hospital Krems)

Short title	Systemische Antitumortherapie am Lebensende
Status	Finished
Effective start/end date	01.04.2022 → 31.03.2024

Funding

Forschungsimpulse

Keywords

Systemische Antitumortherapie am Lebensende
Palliative Care

2 Oral presentation at a conference
1 Review article

Prospective Analysis of Anticancer Treatment Prevalence, Costs, and Impact in Patients with Advanced Cancer
Kreye, G., Feb 2024.
Research output: Contribution to conference › Oral presentation at a conference
Anticancer treatment at the end of life
Kreye, G., Dec 2023.
Research output: Contribution to conference › Oral presentation at a conference
Systemic Anticancer Treatment Near the End of Life: a Narrative Literature Review
Geyer, T., Le, N.-S., Groissenberger, I., Jutz, F., Tschurlovich, L. & Kreye, G., Oct 2023, In: Current Treatment Options in Oncology. 24, 10, p. 1328-1350 23 p.
Research output: Journal article (peer-reviewed) › Review article

Open Access
12 Citations (Scopus)